X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Etoricoxib is a selective COX-2 inhibitor (a coxib) and so an anti-inflammatory painkiller from the NSAID family. It is considerably gentler on the stomach lining than ibuprofen or diclofenac, but it pushes blood pressure up more strongly than the other drugs in the group. Untreated or poorly controlled high blood pressure is therefore a reason not to use it.
See more detail.gif)
Record how long you have been taking it and keep your blood pressure readings alongside — free in the brite app.
| Property | Details |
|---|---|
| Active ingredient | Etoricoxib |
| ATC code | M01AH05 |
| Drug class | Selective COX-2 inhibitor (a "coxib"), a subgroup of the non-steroidal anti-inflammatory drugs (NSAIDs) |
| Dosage forms | Film-coated tablets, usually 30 mg, 60 mg, 90 mg and 120 mg |
| Half-life | Around 22 hours — which is why one dose a day is enough |
| Maximum daily dose | Varies with the indication; according to the SmPC, 120 mg is reserved for an acute gout attack and limited to a few days |
| Onset of effect | Pain relief usually within about an hour |
| Breakdown | Predominantly in the liver, mainly via the enzyme CYP3A4 |
| Prescription status | Prescription-only medicine |
| Notable feature | Markedly gentler on the stomach than classic NSAIDs; in exchange, the most pronounced rise in blood pressure of the group |
Pain and inflammation arise, among other routes, through messenger substances called prostaglandins. They are produced by two related enzymes: COX-1 and COX-2.¹
Classic NSAIDs such as ibuprofen or diclofenac inhibit both enzymes. That is why they work well against inflammatory pain — and attack the stomach's protection at the same time. Etoricoxib inhibits COX-2 specifically and largely leaves COX-1 alone. From that follows its main advantage: markedly fewer stomach ulcers and stomach bleeds.
The catch sits in the same mechanism. COX-2 is not only an inflammation enzyme; it is also involved in regulating blood pressure and the salt and water balance in the kidney. If it is inhibited, the body holds back more sodium and water, and the regulation of the blood vessels shifts. That is exactly where the property that sets this drug apart from the others comes from: blood pressure rises — with etoricoxib as a rule more strongly than with other NSAIDs, and markedly dose-dependently.¹,²
Etoricoxib is an anti-inflammatory painkiller and is used where inflammation is what drives the pain.
Where joint pain is unexplained, the cause belongs on the table before anti-inflammatory treatment is given long term. How the common painkillers differ is set out in the guide painkillers compared.
The details below describe what the SmPC sets out as the usual approach. They are not a dosing instruction — the strength and the duration are set by the treating practice.
So that "short term" does not quietly turn into long-term treatment.
All NSAIDs can push blood pressure up. With etoricoxib, though, this effect is particularly pronounced and dose-dependent — it is the main reason why this drug is handled more strictly than other painkillers from the same family.¹,²
The mechanism is well known: inhibiting COX-2 in the kidney means fewer vessel-widening messengers are formed, sodium and water are held back, and the blood volume rises. The result is a rise that creeps in over weeks and, without measurement, simply goes unnoticed — high blood pressure does not hurt.
Always measure under the same conditions: at rest, sitting, after a few minutes' pause, ideally in the morning and in the evening. The instructions are in the guide measuring blood pressure correctly. A series of readings is worth incomparably more at your next appointment than the sentence "it was always fine, really".
The reason etoricoxib is prescribed at all is usually the stomach. Anyone who does not tolerate classic NSAIDs, or who has an increased risk of bleeding, benefits from the COX-2 selectivity. The comparison is still worth making in detail.
| Active ingredient | Gastrointestinal risk | Blood pressure & cardiovascular | What matters in practice |
|---|---|---|---|
| Etoricoxib | The most favourable of the four — markedly fewer ulcers and bleeds | The strongest rise in blood pressure; a cardiovascular risk is present | Once daily; contraindicated where high blood pressure is not adequately controlled |
| Ibuprofen | Moderate risk, dose-dependent | Moderate; can weaken the effect of low-dose aspirin | Available without prescription in small packs — and therefore often underestimated |
| Diclofenac | A higher risk than ibuprofen | An unfavourable cardiovascular profile | Used sparingly where there is heart disease |
| Naproxen | A higher stomach risk | Regarded as comparatively favourable in cardiovascular terms | A long duration of action, often taken twice daily |
Within the same family there is a second coxib available, celecoxib, which is regarded as having somewhat less effect on blood pressure. Which drug fits is therefore not a question of potency alone but of your individual risk profile: the stomach against the heart, the circulation and the kidneys.
A common misunderstanding goes: "coxibs are the gentle NSAIDs." That holds for the stomach — and for the stomach only. All the other NSAID risks remain.²
Like other NSAIDs, etoricoxib can increase the risk of a heart attack and a stroke, and increasingly so with dose and duration. Where coronary heart disease is present, after a heart attack or a stroke, with peripheral arterial disease and with heart failure of moderate severity or worse, etoricoxib is contraindicated according to the SmPC. With heart failure there is the added point that fluid retention can make the condition itself worse.
The COX enzymes help regulate the blood flow through the kidney. If COX-2 is inhibited, the filtration rate falls — with healthy kidneys usually without consequence, with pre-existing damage not. It becomes critical when several factors come together: etoricoxib plus a diuretic (water tablet) plus a sartan or an ACE inhibitor, and on top of that a gastrointestinal infection or a heatwave. With chronic kidney disease, etoricoxib is therefore used only with restrictions or not at all; the details are in the guide medications for kidney and liver disease.
Under etoricoxib, rises in the liver values occur more often than under some other NSAIDs, particularly with prolonged treatment at higher strengths. The SmPC therefore provides for checks of the liver values, above all where treatment is continuous. Where the values are clearly raised, or where the skin or the eyes turn yellow, the urine is dark or nausea persists, the treatment is stopped. How to make sense of the results is explained in the guide understanding blood values.
| Combination | Consequence | What to do |
|---|---|---|
| Blood-pressure-lowering drugs such as ramipril, sartans, amlodipine, diuretics | The blood-pressure-lowering effect is weakened; blood pressure rises despite treatment | Measure blood pressure closely; use etoricoxib for as short a time as possible |
| A diuretic + an ACE inhibitor or a sartan at the same time | A markedly increased risk of acute kidney failure | Have this triple combination checked specifically with your practice or pharmacy |
| Low-dose aspirin | The coxib's stomach advantage is partly cancelled out, more stomach risk | Discuss gastric protection; never leave the aspirin out on your own |
| Anticoagulants such as phenprocoumon | Clotting values can shift, a higher risk of bleeding | INR checks at the start and at the end of the treatment |
| Methotrexate and lithium | Levels can rise | Checks and medical supervision |
| Other NSAIDs or corticosteroids | An added gastrointestinal risk with no additional benefit | Do not combine, or only on explicit instruction |
| Alcohol | A higher risk of stomach bleeding, additional strain on the liver | Go easy, see medications and alcohol |
The first row is the one with the greatest everyday consequences: anyone who takes a blood pressure tablet and starts etoricoxib on top can suddenly have worse readings although nothing about the tablets has changed — and then wonders about the blood pressure tablet instead of the painkiller. Check new combinations in the guide drug interactions or directly in the interaction check in the brite app.
In older age, the gastrointestinal, cardiovascular and kidney risks all rise. At the same time, blood pressure tablets, diuretics and anticoagulants are more often in play — that is to say, exactly the combinations from section 9. So this applies with particular force here: the lowest strength, the shortest duration, clear review appointments. The guides medications in old age and polypharmacy offer orientation.
Etoricoxib is not suitable, according to the SmPC, where among other things there is an active stomach or duodenal ulcer, gastrointestinal bleeding, inflammatory bowel disease, severe impairment of liver function, markedly reduced kidney function, heart failure of moderate severity or worse, known cardiovascular disease, or high blood pressure that is not adequately controlled.
Yes, and precisely then. The rise in blood pressure under etoricoxib creeps in over days to weeks and causes no complaints. Without a baseline and without a check in the first two weeks it simply does not get noticed — until it is picked up at a routine appointment and nobody thinks of the painkiller any more. Two minutes of measuring a day solves this problem completely.
The effect really is powerful, and that is exactly what makes continuous use tempting. But the cardiovascular risk, the effect on blood pressure and the strain on the kidneys all increase with dose and duration. If pain persists, the right question is not "which painkiller for longer" but "what treats the cause" — physiotherapy, movement, taking weight off the joint, disease-modifying treatment in rheumatic disease, uric-acid-lowering treatment in gout.
Not automatically. The whole point of a coxib is to make gastric protection unnecessary. It looks different where additional risk factors are present: low-dose aspirin, a previous stomach ulcer, corticosteroids, anticoagulants or older age. A proton pump inhibitor can then make sense. That is a medical decision, not a matter for self-medication.
No. Two NSAIDs at the same time add up the risks for the stomach, the kidneys and the circulation without increasing the benefit accordingly. If the effect is not enough, that belongs in a conversation — what can be combined are drugs with a different point of attack, such as paracetamol or metamizole after checking.
The interaction check shows critical combinations before you take them.
How long you have been taking it, your blood pressure over time and an interaction check in one place. Free.
Create medication plan